People with a history of pancreatitis are often advised to avoid GLP-1 medications, but those without prior risk factors do not appear to be at increased risk with long term use
Administering a low dose of the injection below the standard dose
No, dosing adjustments should be individualized based on patient response, tolerance, and overall health goals
Neurosci Lett 569:7479 Liberati A, Altman DG, Tetzlaff J et al (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
Obviously, there are some risks involved with purchasing a longer plan, i.e., theres always the chance that you want to discontinue the medication before the 6-month or 1-year mark, and I am not sure what that would look like
PD-L1 expression with immune-infiltrate evaluation and outcome prediction in melanoma patients treated with ipilimumab